Back to results
US 2003/0229040 A1Published application
Cationic liposomal delivery system and therapeutic use thereof
AssigneeGeorgetown University
InventorsUsha Kasid, Prafulla Gokhale, Chuanbo Zhang, Anatoly Dritschilo, Aquilur Rahman
Life of this patent
Estimating the term…
Abstract
The invention relates to novel cationic lipid formulations and use thereof for treatment of cancer, especially in combination with radiation.
Claims10
A method of radiosensitizing raf oncogene expressing tumor tissue in a subject in need of such treatment comprising administering a radiosensitizing effective amount of a cationic liposomal formulation comprising at least one cationic lipid selected from the group consisting of dimethyldioctadecyl ammonium bromide (DDAB);
- 1,2-dioleoyl-3-trimethyl ammonium propane (DOTAP), N-(2,3-(dioleoyloxy)propyl)-N,N,N-trimethly ammonium chloride;
- 1-[2-(9(Z)-octadecenoyloxy)-ethyl]-2-(8(Z) heptadecenyl)-3-(2-hydroxyethyl)-imidazolinium chloride);
- and 1,2-dimyristoyl-3-trimethyl ammonium propane (DMTAP);
- and further comprising phosphatidylcholine and cholesterol;
- and further having encapsulated therein at least one antisense oligonucleotide that is at most 40 bases which specifically binds to a Raf-1 nucleic acid sequence expressed by said tumor tissue.
2 more elements
Dependencies are inferred from the claim text.